{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:39:53Z","timestamp":1792197593748,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U01DK140923-01"],"award-info":[{"award-number":["1U01DK140923-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50859-7","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:14:45Z","timestamp":1777544085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prebiotic intervention changes host and microbe proteomes in plasma extracellular vesicles of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Deepak","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaisa M.","family":"Cantu-Jungles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliha","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip A.","family":"Engen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Hamaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Bishehsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika G. Marques","family":"de Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7969-3369","authenticated-orcid":false,"given":"Ali","family":"Keshavarzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"50859_CR1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes, M. T. Parkinson\u2019s disease and Parkinsonism. Am. J. Med. 132, 802\u2013807 (2019).","journal-title":"Am. J. Med."},{"key":"50859_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Diagnosis and treatment of Parkinson disease: A review. JAMA 323, 548\u2013560 (2020).","journal-title":"JAMA"},{"issue":"Suppl 1","key":"50859_CR3","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.parkreldis.2015.09.048","volume":"22","author":"M Delenclos","year":"2016","unstructured":"Delenclos, M., Jones, D. R., McLean, P. J. & Uitti, R. J. Biomarkers in Parkinson\u2019s disease: Advances and strategies. Parkinsonism Relat. Disord. 22 (Suppl 1), S106\u2013110 (2016).","journal-title":"Parkinsonism Relat. Disord"},{"key":"50859_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/mds.29317","volume":"38","author":"S Virameteekul","year":"2023","unstructured":"Virameteekul, S., Revesz, T., Jaunmuktane, Z., Warner, T. T. & De Pablo-Fern\u00e1ndez, E. Clinical diagnostic accuracy of Parkinson\u2019s disease: Where do we stand? Mov. Disord Off J. Mov. Disord Soc. 38, 558\u2013566 (2023).","journal-title":"Mov. Disord Off J. Mov. Disord Soc."},{"key":"50859_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/mdc3.12840","volume":"6","author":"C Bullich","year":"2019","unstructured":"Bullich, C., Keshavarzian, A., Garssen, J., Kraneveld, A. & Perez-Pardo, P. Gut vibes in Parkinson\u2019s disease: The microbiota-gut-brain axis. Mov. Disord Clin. Pract. 6, 639\u2013651 (2019).","journal-title":"Mov. Disord Clin. Pract."},{"key":"50859_CR6","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1111\/ene.15671","volume":"30","author":"S Kleine Bardenhorst","year":"2023","unstructured":"Kleine Bardenhorst, S. et al. Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis. Eur. J. Neurol. 30, 3581\u20133594 (2023).","journal-title":"Eur. J. Neurol."},{"key":"50859_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh, J. S. et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal. Transduct. Target. Ther. 9, 37 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"50859_CR8","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1053\/j.gastro.2020.10.066","volume":"160","author":"KG Margolis","year":"2021","unstructured":"Margolis, K. G., Cryan, J. F. & Mayer, E. A. The microbiota-gut-brain axis: From motility to mood. Gastroenterology 160, 1486\u20131501 (2021).","journal-title":"Gastroenterology"},{"key":"50859_CR9","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian, A. et al. Colonic bacterial composition in Parkinson\u2019s disease. Mov. Disord Off J. Mov. Disord Soc. 30, 1351\u20131360 (2015).","journal-title":"Mov. Disord Off J. Mov. Disord Soc."},{"key":"50859_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano, S. et al. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Park Dis. 7, 27 (2021).","journal-title":"NPJ Park Dis."},{"key":"50859_CR11","first-page":"e00462","volume":"21","author":"AM Hamilton","year":"2024","unstructured":"Hamilton, A. M., Krout, I. N., White, A. C. & Sampson, T. R. Microbiome-based therapeutics for Parkinson\u2019s disease. Neurother. J. Am. Soc. Exp. Neurother. 21, e00462 (2024).","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"50859_CR12","first-page":"e73150","volume":"16","author":"SB Suresh","year":"2024","unstructured":"Suresh, S. B. et al. Gut Microbiome and its role in Parkinson\u2019s disease. Cureus 16, e73150 (2024).","journal-title":"Cureus"},{"key":"50859_CR13","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41467-023-36497-x","volume":"14","author":"DA Hall","year":"2023","unstructured":"Hall, D. A. et al. An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson\u2019s disease participants. Nat. Commun. 14, 926 (2023).","journal-title":"Nat. Commun."},{"key":"50859_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.20517\/evcna.2024.56","volume":"5","author":"X Zhao","year":"2024","unstructured":"Zhao, X. & Huang, S. Plasma extracellular vesicle: a novel biomarker for neurodegenerative disease diagnosis. Extracell. Vesicles Circ. Nucleic Acids. 5, 569\u2013573 (2024).","journal-title":"Extracell. Vesicles Circ. Nucleic Acids"},{"key":"50859_CR15","doi-asserted-by":"publisher","first-page":"175628642211503","DOI":"10.1177\/17562864221150329","volume":"16","author":"L Chan","year":"2023","unstructured":"Chan, L., Chung, C. C., Hsieh, Y. C., Wu, R. M. & Hong, C. T. Plasma extracellular vesicle tau, \u03b2-amyloid, and \u03b1-synuclein and the progression of Parkinson\u2019s disease: a follow-up study. Ther. Adv. Neurol. Disord. 16, 17562864221150329 (2023).","journal-title":"Ther. Adv. Neurol. Disord"},{"key":"50859_CR16","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.3390\/ijms22158163","volume":"22","author":"A Alberro","year":"2021","unstructured":"Alberro, A., Iparraguirre, L., Fernandes, A. & Otaegui, D. Extracellular vesicles in blood: Sources, effects, and applications. Int. J. Mol. Sci. 22, 8163 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"50859_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.15252\/embr.201439363","volume":"16","author":"JS Schorey","year":"2015","unstructured":"Schorey, J. S., Cheng, Y., Singh, P. P. & Smith, V. L. Exosomes and other extracellular vesicles in host\u2013pathogen interactions. EMBO Rep. 16, 24\u201343 (2015).","journal-title":"EMBO Rep."},{"key":"50859_CR18","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3390\/genes12101636","volume":"12","author":"E Jones","year":"2021","unstructured":"Jones, E. et al. The origin of plasma-derived bacterial extracellular vesicles in healthy individuals and patients with inflammatory bowel disease: A pilot study. Genes 12, 1636 (2021).","journal-title":"Genes"},{"key":"50859_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"50859_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12967-017-1175-y","volume":"15","author":"RK Singh","year":"2017","unstructured":"Singh, R. K. et al. Influence of diet on the gut microbiome and implications for human health. J. Transl Med. 15, 73 (2017).","journal-title":"J. Transl Med."},{"key":"50859_CR21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/mds.10473","volume":"18","author":"Movement Disorder Society Task Force on Rating Scales for Parkinson\u2019s Disease","year":"2003","unstructured":"Movement Disorder Society Task Force on Rating Scales for Parkinson\u2019s Disease. The unified Parkinson\u2019s disease rating scale (UPDRS): status and recommendations. Mov. Disord Off J. Mov. Disord Soc. 18, 738\u2013750 (2003).","journal-title":"Mov. Disord Off J. Mov. Disord Soc."},{"key":"50859_CR22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/mdc3.12476","volume":"4","author":"M Skorvanek","year":"2017","unstructured":"Skorvanek, M. et al. Differences in MDS-UPDRS scores based on Hoehn and Yahr stage and disease duration. Mov. Disord Clin. Pract. 4, 536\u2013544 (2017).","journal-title":"Mov. Disord Clin. Pract."},{"key":"50859_CR23","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J. Extracell. Vesicles. 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"50859_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0003-2697(84)90782-6","volume":"138","author":"D Wessel","year":"1984","unstructured":"Wessel, D. & Fl\u00fcgge, U. I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138, 141\u2013143 (1984).","journal-title":"Anal. Biochem."},{"key":"50859_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/proteomes9010015","volume":"9","author":"BC Orsburn","year":"2021","unstructured":"Orsburn, B. C. Proteome discoverer-A community enhanced data processing suite for protein informatics. Proteomes 9, 15 (2021).","journal-title":"Proteomes"},{"key":"50859_CR26","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1021\/pr500473n","volume":"13","author":"M Lavall\u00e9e-Adam","year":"2014","unstructured":"Lavall\u00e9e-Adam, M., Rauniyar, N., McClatchy, D. B. & Yates, J. R. PSEA-Quant: A protein set enrichment analysis on label-free and label-based protein quantification data. J. Proteome Res. 13, 5496\u20135509 (2014).","journal-title":"J. Proteome Res."},{"key":"50859_CR27","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"UniProt Consortium","year":"2023","unstructured":"UniProt Consortium. UniProt: the Universal protein knowledgebase in 2023. Nucleic Acids Res. 51, D523\u2013D531 (2023).","journal-title":"Nucleic Acids Res."},{"key":"50859_CR28","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301\u20132319 (2016).","journal-title":"Nat. Protoc."},{"key":"50859_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"50859_CR30","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013D678 (2024).","journal-title":"Nucleic Acids Res."},{"key":"50859_CR31","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1093\/bioinformatics\/btv183","volume":"31","author":"BJ Kelly","year":"2015","unstructured":"Kelly, B. J. et al. Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinforma Oxf. Engl. 31, 2461\u20132468 (2015).","journal-title":"Bioinforma Oxf. Engl."},{"key":"50859_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41586-021-03222-x","volume":"591","author":"D Sharma","year":"2021","unstructured":"Sharma, D. et al. The kinetic landscape of an RNA-binding protein in cells. Nature 591, 152\u2013156 (2021).","journal-title":"Nature"},{"key":"50859_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41531-024-00753-8","volume":"10","author":"Y Dai","year":"2024","unstructured":"Dai, Y. et al. Astrocyte-derived apolipoprotein D is required for neuronal survival in Parkinson\u2019s disease. NPJ Park Dis. 10, 143 (2024).","journal-title":"NPJ Park Dis."},{"key":"50859_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/1742-2094-9-259","volume":"9","author":"S Cao","year":"2012","unstructured":"Cao, S., Standaert, D. G. & Harms, A. S. The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia. J. Neuroinflammation. 9, 259 (2012).","journal-title":"J. Neuroinflammation"},{"key":"50859_CR35","doi-asserted-by":"publisher","unstructured":"L\u00f3pez, O. A. M., L\u00f3pez, A. M., Crossa, D. J. & Overfitting model tuning, and evaluation of prediction performance. In Multivariate Statistical Machine Learning Methods for Genomic Prediction https:\/\/doi.org\/10.1007\/978-3-030-89010-0_4. (Springer, 2022).","DOI":"10.1007\/978-3-030-89010-0_4"},{"key":"50859_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Diagnosis and treatment of Parkinson disease: A review. JAMA 323, 548\u2013560 (2020).","journal-title":"JAMA"},{"key":"50859_CR37","doi-asserted-by":"publisher","first-page":"12379","DOI":"10.3390\/ijms252212379","volume":"25","author":"R Arya","year":"2024","unstructured":"Arya, R. et al. Parkinson\u2019s disease: Biomarkers for diagnosis and disease progression. Int. J. Mol. Sci. 25, 12379 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"50859_CR38","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1111\/ejn.16290","volume":"59","author":"C Liu","year":"2024","unstructured":"Liu, C., Su, Y., Ma, X., Wei, Y. & Qiao, R. How close are we to a breakthrough? The hunt for blood biomarkers in Parkinson\u2019s disease diagnosis. Eur. J. Neurosci. 59, 2563\u20132576 (2024).","journal-title":"Eur. J. Neurosci."},{"key":"50859_CR39","first-page":"147","volume":"33","author":"A Sulek","year":"2024","unstructured":"Sulek, A. Secretome - the role of extracellular vesicles in the pathogenesis and therapy of neurodegenerative diseases. Postepy Psychiatr Neurol. 33, 147\u2013162 (2024).","journal-title":"Postepy Psychiatr Neurol."},{"key":"50859_CR40","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/mds.28639","volume":"36","author":"A Stuendl","year":"2021","unstructured":"Stuendl, A. et al. \u03b1-Synuclein in plasma-derived extracellular vesicles Is a potential biomarker of Parkinson\u2019s disease. Mov. Disord Off J. Mov. Disord Soc. 36, 2508\u20132518 (2021).","journal-title":"Mov. Disord Off J. Mov. Disord Soc."},{"key":"50859_CR41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/genes14010226","volume":"14","author":"J Xue","year":"2023","unstructured":"Xue, J., Li, F. & Dai, P. The potential of ANK1 to predict Parkinson\u2019s disease. Genes 14, 226 (2023).","journal-title":"Genes"},{"key":"50859_CR42","doi-asserted-by":"publisher","first-page":"782082","DOI":"10.3389\/fnagi.2021.782082","volume":"13","author":"EM Klann","year":"2021","unstructured":"Klann, E. M. et al. The gut-brain axis and Its relation to Parkinson\u2019s disease: A review. Front. Aging Neurosci. 13, 782082 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"50859_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/bs.pmbts.2020.11.001","volume":"177","author":"G Forloni","year":"2021","unstructured":"Forloni, G., La Vitola, P., Cerovic, M. & Balducci, C. Inflammation and Parkinson\u2019s disease pathogenesis: Mechanisms and therapeutic insight. Prog Mol. Biol. Transl Sci. 177, 175\u2013202 (2021).","journal-title":"Prog Mol. Biol. Transl Sci."},{"key":"50859_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mi.2016.75","volume":"10","author":"MY Zeng","year":"2017","unstructured":"Zeng, M. Y., Inohara, N. & Nu\u00f1ez, G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 10, 18\u201326 (2017).","journal-title":"Mucosal Immunol."},{"key":"50859_CR45","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3390\/microorganisms12091864","volume":"12","author":"D Li","year":"2024","unstructured":"Li, D. et al. Lactic acid bacteria-gut-microbiota-mediated intervention towards inflammatory bowel disease. Microorganisms 12, 1864 (2024).","journal-title":"Microorganisms"},{"key":"50859_CR46","doi-asserted-by":"publisher","first-page":"zsaf191","DOI":"10.1093\/sleep\/zsaf191","volume":"48","author":"A Ibrahim","year":"2025","unstructured":"Ibrahim, A., S\u00fczg\u00fcn, M. A. & Stefani, A. Blood will tell: plasma biomarkers in isolated REM sleep behavior disorder. Sleep 48, zsaf191 (2025).","journal-title":"Sleep"},{"key":"50859_CR47","first-page":"297","volume":"13","author":"LM Chahine","year":"2023","unstructured":"Chahine, L. M. et al. Proposal for a biologic staging system of Parkinson\u2019s disease. J. Park Dis. 13, 297\u2013309 (2023).","journal-title":"J. Park Dis."},{"key":"50859_CR48","doi-asserted-by":"publisher","first-page":"e210279","DOI":"10.1212\/WNL.0000000000210279","volume":"104","author":"DG Coughlin","year":"2025","unstructured":"Coughlin, D. G. et al. \u03b1-Synuclein seed amplification assay amplification parameters and the risk of progression in prodromal Parkinson disease. Neurology 104, e210279 (2025).","journal-title":"Neurology"},{"key":"50859_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/ana.70028","author":"M Fabbri","year":"2025","unstructured":"Fabbri, M. et al. Disease progression in multiple system atrophy: The ASPIRE multi-modal biomarker study. Ann. Neurol. https:\/\/doi.org\/10.1002\/ana.70028 (2025).","journal-title":"Ann. Neurol."},{"key":"50859_CR50","doi-asserted-by":"publisher","first-page":"e187792","DOI":"10.1172\/jci.insight.187792","volume":"10","author":"X Deng","year":"2025","unstructured":"Deng, X. et al. Donor genetics and storage conditions influence mitochondrial DNA and extracellular vesicle levels in RBC units. JCI Insight. 10, e187792 (2025).","journal-title":"JCI Insight"},{"key":"50859_CR51","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.3390\/ijms25063478","volume":"25","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Extracellular vesicles: A crucial player in the intestinal microenvironment and beyond. Int. J. Mol. Sci. 25, 3478 (2024).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50859-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50859-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50859-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:03:02Z","timestamp":1782928982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50859-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50859"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50859-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"(1) The prebiotic bar was developed by RiteCarbs LLC which is co-owned by Drs. Keshavarzian, Hamaker and Cantu-Jungles. A provisional patent is pending for the prebiotic mixture used in the bar (Patent Applicant: Purdue Research Foundation, Inventors: Drs. Keshavarzian, Hamaker, Cantu-Jungles Application Number: 18579679, Status: Pending, Patent covers the use of prebiotics to improve health). Drs. Keshavarzian, Hamaker, and Cantu-Jungles were not involved in participant recruitment, participant assessments, or statistical analysis of the data. (2) Dr. Deepak Sharma is the founder and Chief Scientific Officer of Bainom Inc. (3) Dr. Goetz is on the consulting or advisory board for Theranova, Genentech, Psychogenics Inc, Csg Health Group, and CHDI, and receives a faculty stipend and Program Management stipend from the International Parkinson and Movement Disorder Society and a Volume Editor stipend from Elsevier Publishers. Royalties from Elsevier Publishers, Wolters Kluwer, Oxford University Press. (4) The remaining authors declare no competing interests. Research funding from NIH (NIDDK), the Department of Defense, and Michael J Fox Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20095"}}